Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-75
Closed -$6K – 434
2022
Q1
$6K Sell
75
-75
-50% -$7.19K ﹤0.01% 235
2021
Q4
$18K Hold
150
– – ﹤0.01% 200
2021
Q3
$19K Hold
150
– – ﹤0.01% 384
2021
Q2
$18K Hold
150
– – ﹤0.01% 427
2021
Q1
$16K Hold
150
– – ﹤0.01% 238
2020
Q4
$15K Hold
150
– – ﹤0.01% 171
2020
Q3
$13K Sell
150
-400
-73% -$31.1K ﹤0.01% 135
2020
Q2
$36K Hold
550
– – ﹤0.01% 84
2020
Q1
$36K Hold
550
– – ﹤0.01% 86
2019
Q4
$43K Hold
550
– – ﹤0.01% 97
2019
Q3
$44K Hold
550
– – 0.01% 98
2019
Q2
$46K Hold
550
– – 0.01% 95
2019
Q1
$43K Sell
550
-1,900
-78% -$139K 0.01% 91
2018
Q4
$163K Hold
2,450
– – 0.02% 43
2018
Q3
$196K Buy
2,450
+1,900
+345% +$142K 0.03% 41
2018
Q2
$37K Buy
+550
New +$39.9K 0.01% 55

Other funds holding XYL

Sageworth Trust's XYL Position: Q2 2022 in Review

Sageworth Trust sold out of Xylem (XYL) in Q2 2022, closing a stake of 75 shares — an estimated $6K sold.

Sageworth Trust first reported a position in XYL in Q2 2018 and held it in 16 quarters. The position peaked at $196K in Q3 2018. 725 funds tracked by Wall St. Rank hold XYL as of Q2 2022.

  • Sageworth Trust reported no remaining Xylem position as of Q2 2022 after selling out during the quarter.
  • Sageworth Trust sold 75 Xylem shares in Q2 2022, an estimated $6K.
  • Sageworth Trust first reported a position in Xylem in Q2 2018 and held it in 16 quarters.
  • Sageworth Trust's Xylem position peaked at $196K in Q3 2018.
  • 725 funds tracked by Wall St. Rank held Xylem as of Q2 2022.

Based on Sageworth Trust's 13F filing for Q2 2022, filed 28 Jul 2022.